Search the Newsreel

Sona Asset Management US LLC Takes $6.97 Million Position in Qorvo, Inc. $QRVO

Sona Asset Management US LLC has taken a new position in Qorvo, Inc., acquiring 90,046 shares valued at approximately $6.97 million. This comes as institutional ownership in Qorvo stands at 88.57%, while several insiders, including the CEO, have sold significant shares in recent months. …

CorVel's Aug. 5 Earnings Webcast Will Include Investor Q&A

CorVel (NASDAQ: CRVL) announced it will host a live webcast on Wednesday, August 5, 2026, at 11:30 AM Eastern Time to discuss its upcoming quarterly earnings results. The webcast will feature Executive Chairman Michael Combs, CEO Sarah Scott, and CFO Brian Nichols, who will …

Qorvo stock trades steady as RF demand supports margin recovery

Qorvo Inc. is demonstrating a mixed recovery with strong demand for RF solutions and cost management driving an earnings rebound, though revenue remains below previous highs. The company's profitability has improved significantly, moving from a net loss to a net profit, primarily due to …

Walleye Capital LLC Sells 52,943 Shares of CorVel Corp. $CRVL

Walleye Capital LLC significantly reduced its stake in CorVel Corp. by selling 93% of its shares in the first quarter, leaving it with 4,009 shares. Despite this large sale, institutional ownership in CorVel remains high at 51.36%, with other firms increasing their positions. The …

Granahan Investment Management LLC Has $4.37 Million Stock Position in CorVel Corp. $CRVL

Granahan Investment Management LLC increased its stake in CorVel Corp. by 36.2% in the first quarter, now holding 79,896 shares valued at approximately $4.37 million. The business services provider's stock was trading around $59.86, with a market capitalization of $3.05 billion and a P/E …

Corvus Pharmaceuticals Inc (CRVS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Corvus Pharmaceuticals Inc (CRVS), including its stock price, market cap, and a note that P/E, P/B, and P/CF data are not yet disclosed by the company. It lists various sections for stock analysis like Financials, Discussions, Analysis, …

Corvus Pharmaceuticals Inc (CRVS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Corvus Pharmaceuticals Inc (CRVS), detailing its support, resistance, and various indicator readings. It covers commonly used technical indicators like MACD, RSI, and moving averages, offering a summary of buy, sell, and neutral signals. The analysis aims to …

Renaissance Technologies LLC Sells 68,500 Shares of CorVel Corp. $CRVL

Renaissance Technologies LLC decreased its holding in CorVel Corp. by 4.1% in the first quarter, selling 68,500 shares. This move means Renaissance now holds 1,617,830 shares of CRVL, valued at approximately $88.4 million. Insider selling also continued, with two executives selling 13,249 shares in …

Qorvo stock trades steady as latest quarterly results highlight mixed demand and margin resilience

Qorvo Inc. is managing mixed demand with its recent quarterly results, showing a decline in smartphone-related revenue but stability from its infrastructure and defense segments. The company reported around $900 million in revenue, a 10% year-on-year drop, but maintained a gross margin above 30%. …

Qorvo, Inc. $QRVO Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its stake in Qorvo, Inc. (NASDAQ:QRVO) by 16.7% in the first quarter, now owning 2.35% of the company's stock. Other institutional investors also adjusted their positions, with 88.57% of القورvo's stock owned by institutional investors and hedge funds. Analysts …

Corvus Pharmaceuticals (CRVS) Board Resignation Puts Leadership Outlook In Focus

CorVel Corp. (CRVL) Stock Forecasts

Argus has lowered its target price for CorVel Corp. (CRVL) to $66.00. CorVel Corp. utilizes artificial intelligence, machine learning, and natural language processing to manage healthcare episodes and associated costs. The current stock price for CRVL is $59.86.

CorVel Corp (CRVL) Valuation: PE, PB & Fair Value Analysis

CorVel Corp (CRVL) has a current valuation score of 6.74, ranking 64 out of 75 in its industry. The company's P/E ratio is 27.82, which is significantly below its recent high but above its recent low. Other valuation metrics like P/B, P/S, and P/CF …

CorVel Corp (CRVL) Institutional Confidence

CorVel Corp (CRVL) has an institutional shareholding score of 5.00, placing it 48th in the Healthcare Providers & Services industry. The institutional shareholding proportion is 53.54%, showing a 3.12% decrease quarter-over-quarter. James Simons is the largest institutional shareholder, holding 3.18% of outstanding shares.

CorVel Corp (CRVL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for CorVel Corp (CRVL), highlighting its performance across different business segments and geographical regions. As of FY2026Q3, the company generated $146.06 million (61.99%) from Patient management Services and $89.57 million (38.01%) from Network Solution Services. All of …

Qorvo Inc (QRVO) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Qorvo Inc (QRVO), noting its current valuation score of 8.14, which ranks 56th in the Semiconductors & Semiconductor Equipment industry. The company's P/E ratio stands at 23.63, significantly below its recent high but above its recent low. …

Qorvo, Inc. Revenue Breakdown – NASDAQ:QRVO

Qorvo, Inc. (NASDAQ:QRVO) generated $3.68 billion in revenue last year, with its Advanced Cellular Group segment being the highest earner at $2.55 billion. The United States was the company's largest regional contributor, accounting for $2.32 billion of the revenue. This data provides a snapshot …

Form 4 CorVel Corp For: 24 July By Investing.com

The article is a brief financial market announcement from Investing.com, stating "Form 4 CorVel Corp For: 24 July". It indicates that a Form 4, which typically reports changes in beneficial ownership of securities, has been filed for CorVel Corp on July 24th. No further …

CorVel Corp (CRVL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of CorVel Corp (CRVL), listing its major shareholders and institutional holdings. It provides a breakdown of ownership percentages by both specific entities and types of shareholders, along with trends in institutional ownership over several quarters and current ETF …

Qorvo (QRVO) Q4 2026 earnings summary

Qorvo reported Q4 2026 revenue of $808.3 million, with non-GAAP diluted EPS reaching $1.69, a year-over-year increase. The company repurchased $400 million of shares and ended the quarter with $1.2 billion in cash. For fiscal 2027, Qorvo expects a 53-week year with non-GAAP gross …

Qorvo, Inc. $QRVO Stake Boosted by Caxton Associates LLP

Caxton Associates LLP significantly increased its stake in Qorvo, Inc. (NASDAQ:QRVO) by 2,359.8% in the first quarter, now owning 177,499 shares worth $13.74 million. Other institutional investors like AQR Arbitrage LLC and Norges Bank also acquired new positions or substantially grew their holdings in …

Qorvo Inc. stock underperforms Thursday when compared to competitors

Qorvo Inc. (QRVO) shares fell by 3.07% on Thursday, closing at $86.73, despite a six-day winning streak being broken. This underperformance occurred during a broader market decline, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses.

Qorvo (QRVO) Proxy filing Summary

Qorvo (QRVO) has released its proxy filing summary, detailing the agenda for its annual meeting scheduled for August 11, 2026. Shareholders will vote on the election of ten directors, executive compensation, and the ratification of Ernst & Young LLP as the independent auditor. The …

Qorvo stock trades steady as RF chip maker leans on diversified demand and recent earnings trends

Qorvo stock is trading steadily as the RF chip maker navigates mixed demand in the smartphone and infrastructure sectors. The company is responding to recent

Earnings Preview: Qorvo to Report Financial Results Post-market on July 28

This article announces that Qorvo (QRVO) is scheduled to release its financial results after market close on July 28. Investors will be observing the company's performance and outlook, particularly following a challenging period for semiconductor stocks. The upcoming report will provide insights into Qorvo's …

QRVO5046520 Bond Coupon Profile — Rate & Payments

This article provides the coupon profile for the QRVO5046520 bond issued by Qorvo, Inc., highlighting its interest rate and payment schedule. The bond has a current coupon rate of 3.38%, with the next payment planned for October 1, 2026. It offers an overview of …

Corvus Pharmaceuticals director Ian T. Clark resigns from board

Corvus Pharmaceuticals director Ian T. Clark has resigned from the company's board of directors, effective July 22, 2026. Clark provided notice of his intention to resign the day prior, on July 21, 2026. This news brief was generated by Public Technologies (PUBT) using AI, …

Why Orvana Minerals Corp. stock is rising today

Qorvo stock trades steady as RF chip maker leans on diversification after mixed quarterly results

Qorvo Inc. (QRVO) reported lower quarterly revenue and a net loss, reflecting a mixed performance influenced by cyclical demand for its RF chips. Despite challenges in smartphone markets, the company is focusing on diversification by growing its defense, power management, and infrastructure segments. This …

Korvest (ASX: KOV): Assessing Niche Industrial Business

Is It Too Late to Buy Qorvo Inc (QRVO) After 3.7% Rally? GF Value Says Undervalued

Qorvo Inc (QRVO) shares recently rallied 3.7%, but its current price of $88.90 is still 4.6% below its GF Value™ of $93.14, suggesting it is undervalued. The company has an above-average GF Score™ of 69/100, though its growth rank is low (1/10) and insiders …

Corvus Pharmaceuticals (CRVS) Q1 2026 earnings summary

Corvus Pharmaceuticals (CRVS) reported a net loss of $13.7 million for Q1 2026, a significant decrease from a net income of $15.2 million in Q1 2025 which was largely due to a non-cash gain. The company's operations are focused on advancing its lead candidate, …

Qorvo stock holds steady as revenue and margins frame the outlook

Qorvo stock is being observed by investors who are evaluating the company's reported revenue, margin, and cash-flow against its recent trading levels and the broader semiconductor demand landscape. Although the article confirms Qorvo Inc.'s identity and its ISIN US74736K1016, it notes a lack of …

Qorvo (QRVO) to Post Quarterly Earnings on Tuesday

Qorvo (QRVO) is expected to report its Q1 2027 earnings on Tuesday, July 28th, with analysts forecasting earnings of $1.10 per share and revenue of $743.93 million. The company recently beat expectations for its previous quarter, reporting $1.69 EPS and $808.28 million in revenue, …

Qorvo introduces X-band front-end module for phased array radar applications

Qorvo Inc. has released an X-band transmit/receive front-end module, the QPF5012, for phased array radar systems. This module integrates transmit amplification, receive functionality, and switching, operating across the 8.5-10.5 GHz X-band with 10 watts of saturated transmit power. It is designed to improve efficiency …

Is Qorvo (QRVO) Undervalued After Its Rochester Electronics Supply Deal?

Qorvo (QRVO) has gained renewed attention following a distribution agreement with Rochester Electronics, aiming to broaden access to its RF and power semiconductor products for critical sectors. Despite recent mixed trading performance, with a significant drop over the last five years, the stock is …